FI970113A - Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia - Google Patents

Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia Download PDF

Info

Publication number
FI970113A
FI970113A FI970113A FI970113A FI970113A FI 970113 A FI970113 A FI 970113A FI 970113 A FI970113 A FI 970113A FI 970113 A FI970113 A FI 970113A FI 970113 A FI970113 A FI 970113A
Authority
FI
Finland
Prior art keywords
image
4alkyl
compounds
azolones
sulfonamide derivatives
Prior art date
Application number
FI970113A
Other languages
English (en)
Swedish (sv)
Other versions
FI970113A0 (fi
Inventor
Jan Heeres
Raymond Antoine Stokbroekx
Joseph Hector Mostmans
Der Veken Louis Jozef Elis Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI970113A publication Critical patent/FI970113A/fi
Publication of FI970113A0 publication Critical patent/FI970113A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)
FI970113A 1994-07-12 1997-01-10 Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia FI970113A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202015 1994-07-12
PCT/EP1995/002619 WO1996001818A1 (en) 1994-07-12 1995-07-05 Sulfonamide derivatives of azolones anti-helicobacter agents

Publications (2)

Publication Number Publication Date
FI970113A true FI970113A (fi) 1997-01-10
FI970113A0 FI970113A0 (fi) 1997-01-10

Family

ID=8217029

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970113A FI970113A0 (fi) 1994-07-12 1997-01-10 Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia

Country Status (21)

Country Link
US (2) US5571811A (fi)
EP (1) EP0770071B1 (fi)
JP (1) JPH10502386A (fi)
CN (1) CN1068878C (fi)
AT (1) ATE206706T1 (fi)
AU (1) AU684981B2 (fi)
BR (1) BR9508376A (fi)
CA (1) CA2194562A1 (fi)
CZ (1) CZ2997A3 (fi)
DE (1) DE69523159T2 (fi)
FI (1) FI970113A0 (fi)
HU (1) HUT76636A (fi)
IL (1) IL114537A (fi)
MX (1) MX9700340A (fi)
NO (1) NO970089L (fi)
NZ (1) NZ289853A (fi)
PL (1) PL318149A1 (fi)
SK (1) SK4497A3 (fi)
TW (1) TW341571B (fi)
WO (1) WO1996001818A1 (fi)
ZA (1) ZA955760B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
KR100484326B1 (ko) * 1999-03-17 2005-04-20 모리나가 세이카 가부시키가이샤 코코아 성분을 함유하는 음식물
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
DK1563061T3 (da) * 2002-11-14 2012-10-01 Aderans Res Inst Inc Dyrkning af hårinducerende celler
AU2004221812B2 (en) * 2003-03-19 2010-02-18 Exelixis Inc. Tie-2 modulators and methods of use
TW200626148A (en) * 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
TW200626138A (en) * 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CA2580787A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CN101083992A (zh) 2004-09-20 2007-12-05 泽农医药公司 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物
AU2005286648A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
AR051095A1 (es) * 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso comoinhibidores de la estearoil-coa desaturasa
AR051092A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
EP2269610A3 (en) * 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
CA2618646A1 (en) * 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
AU2020205121A1 (en) * 2019-01-06 2021-08-12 Psomagen Inc. HtrA inhibitors and CagA inhibitors and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
CA2076257A1 (en) * 1991-09-13 1993-03-14 Jan Heeres 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones

Also Published As

Publication number Publication date
AU684981B2 (en) 1998-01-08
EP0770071B1 (en) 2001-10-10
BR9508376A (pt) 1997-10-28
EP0770071A1 (en) 1997-05-02
CN1068878C (zh) 2001-07-25
PL318149A1 (en) 1997-05-12
HU9700080D0 (en) 1997-02-28
IL114537A (en) 1999-04-11
IL114537A0 (en) 1995-11-27
US5571811A (en) 1996-11-05
NO970089L (no) 1997-03-10
ATE206706T1 (de) 2001-10-15
TW341571B (en) 1998-10-01
CZ2997A3 (en) 1997-09-17
SK4497A3 (en) 1997-12-10
DE69523159T2 (de) 2002-06-20
HUT76636A (en) 1997-10-28
ZA955760B (en) 1997-01-13
CA2194562A1 (en) 1996-01-25
US5728700A (en) 1998-03-17
JPH10502386A (ja) 1998-03-03
NO970089D0 (no) 1997-01-09
WO1996001818A1 (en) 1996-01-25
AU2981995A (en) 1996-02-09
CN1152308A (zh) 1997-06-18
NZ289853A (en) 1997-11-24
FI970113A0 (fi) 1997-01-10
MX9700340A (es) 1997-05-31
DE69523159D1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
FI970113A (fi) Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia
MX9700339A (es) Derivados de azolona anti-helcobacter que contienen urea y tiourea.
DK502781A (da) Fremgangsmaade til fremstilling af 3-aryloxy-3-phenylpropylaminer
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
MX9700342A (es) Derivados acilicos de azolonas anti-helicobacter.
DE3360904D1 (de) A fungicidal indanylbenzamide
MX9700338A (es) Derivados heterociclicos de azolona anti-helicobacter.
DE69523581T2 (de) Anti-helicobacter ester- oder carbamatderivate von azolonen
DK428087A (da) Dihydropyridin-5-phosphonsyre-cyclopropylenester
CH653840GA3 (en) Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds